Group 2 innate lymphoid cells (ILC2s) and CD4 + type 2 helper T cells (T H 2 cells) are defined by their similar effector cytokines, which together mediate the features of allergic immunity. We found that tissue ILC2s and T H 2 cells differentiated independently but shared overlapping effector function programs that were mediated by exposure to the tissue-derived cytokines interleukin 25 (IL-25), IL-33 and thymic stromal lymphopoietin (TSLP). Loss of these three tissue signals did not affect lymph node priming, but abrogated the terminal differentiation of effector T H 2 cells and adaptive lung inflammation in a T cell-intrinsic manner. Our findings suggest a mechanism by which diverse perturbations can activate type 2 immunity and reveal a shared local-tissueelicited checkpoint that can be exploited to control both innate and adaptive allergic inflammation.
Pattern-recognition receptors for conserved microbial structural elements and nucleic acids are critical innate sensors that shape the ensuing adaptive responses of the T H 1 and IL-17-producing (T H 17) subsets of helper T cells that protect against bacteria, fungi and viruses. In contrast, allergy and anti-helminth immune responses, also known as 'type 2 immunity' , can be elicited by a wide array of proteases, venoms and mechanical irritants, yet understanding of the sensing pathways by which recognition of these diverse signals converges on adaptive type 2 immunity remains incomplete. The discovery of ILC2s altered the understanding of type 2 immunity. ILC2s are dispersed in peripheral tissues, where they constitute the main innate sources of the cytokines IL-13 and IL-5 (ref. 1) . The ability of ILC2s to rapidly respond to epithelial cytokines, such as IL-33, IL-25 and TSLP, as well as other mediators released during tissue damage 2, 3 , without the need for antigen specificity, has suggested models in which ILC2s instruct adaptive T H 2 responses through their effects on dendritic cells 4 or direct interactions with T H 2 cells [5] [6] [7] [8] [9] [10] . Understanding these relationships is critical for devising strategies to attenuate type 2 immunity by therapeutically targeting shared upstream signals elicited by the wide array of allergens.
The genes encoding the type 2 cytokines IL-4, IL-13 and IL-5 share a highly conserved locus but exhibit divergent expression patterns in different cells and tissues during allergic inflammation 11 . Mice infected with the parasitic nematode Nippostrongylus brasiliensis (Nb), a well-established model of migratory helminth infection, develop lung inflammation that is accompanied by eosinophils, alternatively activated macrophages and high concentrations of immunoglobulin E (IgE) 12 . The T H 2 cells that drive this immune response are initially primed in the draining lymph nodes, as revealed with the 4get reporter strain: CD4 + T cells from these reporter mice express green fluorescent protein (GFP) when their Il4 locus becomes accessible at the time of lymph node priming 13 . Most Il4-expressing T cells in lymph nodes are follicular helper T cells (T FH cells) 11 , but a subset of the 4get + lymph node T cells go on to become effector T H 2 cells that migrate from the lymph node to peripheral tissues, as indicated by their ability to expel worms after adoptive transfer 13 .
We challenged mice carrying cytokine-reporter alleles with a variety of type 2 immune stimuli to delineate the regulation of type 2 immune cytokines in vivo. Unexpectedly, we found that activation of primed T H 2 cells occurred independently of ILC2s or ILC2 cytokines but that the effector function of both cell types was dependent on combinatorial exposure to IL-33, IL-25 and TSLP. Because these signals were not required for lymph node priming of CD4 + T cells, we propose that they constitute a local checkpoint that restricts the differentiation of cytokine-expressing effector cells to sites of tissue damage.
RESULTS

Shared core programming of tissue ILC2s and T H 2 cells
Studies using an IL-13 reporter allele (S13) have shown that T H 2 cells expressing IL-13, which is required for worm clearance, constitute a subset of the larger pool of 4get + T cells 11 . Similarly, using an IL-5 reporter allele (R5) 14 , we found that IL-5-expressing T H 2 cells in the lung constitute a subset of 4get + T cells (Fig. 1a) , consistent with cytokine-expressing effector T H 2 cells differentiating from primed 4get + CD4 + T cells in lymph nodes. ILC2s, which resided and expressed IL-5 in peripheral non-lymphoid tissue in steady state, accumulated in the Nb-infected lung before the arrival of IL-5-expressing T H 2 cells (Fig. 1b and Supplementary Fig. 1a) , and 1 3 8 2 VOLUME 17 NUMBER 12 DECEMBER 2016 nature immunology A r t i c l e s both ll types increased their frequency of R5 + cells and the fluorescent intensity of the reporter with time (Supplementary Fig. 1b) .
To assess the reliability of the reporters in accurately identifying tissue effector lymphocytes, we compared the chromatin landscape of lung ILC2s and T H 2 cells by using the 4get allele to sort primed (4get + ) CD4 + T cells from the lungs of Nb-infected mice and to analyze them along with rigorously gated lung ILC2s using the assay for transposase-accessible chromatin using sequencing (ATAC-Seq) 15 . As a control population, we also analyzed primed (4get + ) CD4 + T cells in the lung-draining lymph nodes that had not migrated to the lung.
Regardless of their tissue of origin, when analyzed across the entire genome, 4get + T cells exhibited chromatin accessibility that was different from that of ILC2s, including differences at expected loci such as Cd4, Arg1 and Il4 (ref. 16) (Supplementary Fig. 2a,b) . Consistent with the cytokine-reporter data, we found that lung 4get + T cells diverged from lymph node 4get + T cells at loci encoding products associated with effector function, including Il5 and Il13 (Fig. 1c) . Furthermore, when we compared these populations at regions previously identified as being effector T cell-specific 'super-enhancers' 17 , lung 4get + T H 2 cells more closely resembled ILC2s than lymph node T cells, with Pearson correlation coefficients of 0.79 and 0.67, respectively (Supplementary Fig. 2c) . Peaks for specific genes encoding products associated with effector function, including Gata3 and Rora, indicated increased chromatin accessibility in these loci among lung tissue ILC2 and effector T cell populations, in contrast with the primed 4get + T cells in lymph nodes (Fig. 1c) . Thus, although the Il4 locus was primed in all lymph node 4get + T cells, and although this pool includes cells with effector T H 2 cell potential 10 , chromatin accessibility at the Il5 and Il13 loci showed enrichment only among 4get + T cells that had exited the lymph node and entered the inflamed tissue.
The epigenetic similarities between lung ILC2s and tissue effector T H 2 cells suggested that chromatin accessibility in these tissue-resident cells directs a shared gene expression program. To test this hypothesis, we used the IL-5 reporter allele to isolate actively cytokine-expressing T H 2 cells from the lungs of Nbinfected mice and compared their transcriptional profile with that of IL-5-expressing ILC2s by RNA sequencing (RNA-Seq). We found that ILC2s and tissue effector T H 2 cells shared expression of genes encoding cell-surface receptors and cytokines (Fig. 1d,  Supplementary Fig. 2d and Supplementary Tables 1-3) , which suggested that they sense and respond similarly to the tissue microenvironment. Indeed, many genes encoding transcription factors that are important for ILC2 differentiation and/or function 18 were similarly expressed in tissue effector T H 2 cells (Fig. 1d, Supplementary  Fig. 2d and Supplementary Tables 1-3 ). 
IL-5 producers drive type 2 immunity in non-lymphoid tissue
The transcriptional and epigenetic similarities of these cytokinecompetent tissue-localized effector lymphocytes that we observed, including their high expression of Rora, suggested that prior ILC2-deletion strategies [4] [5] [6] 19, 20 might have been complicated by potential cell-intrinsic effects on tissue effector T H 2 cells. In addition, reconstitution strategies in other models of ILC2 deficiency, such as common γ-cytokine receptor chain or the IL-7 receptor α-chain, are limited by aberrant lymph node development that precludes accurate assessments of T H 2 differentiation 21 . In R5 reporter mice infected with Nb, the only cells expressing R5 were ILC2s and T H 2 cells (Supplementary Fig. 3a) , and, as previously shown with dual IL-5-IL-13 reporter mice 11 , all of the IL-13-expressing ILC2s were contained in the R5 hi subset (Fig. 2a) . On the basis of that finding, we crossed R5/R5 mice, whose cells carry sequence encoding a Cre recombinase element in Il5, to mice carrying a ROSA26-flox stop-diphtheria toxin A 'Deleter' allele 22 to delete activated effector cells. In the resultant R5 Deleter mice, 90% of lung ILC2s, which constitutively express IL-5, were deleted at rest (ref. 14) (Supplementary Fig. 3b ), and 5 d and 10 d after Nb infection, worm clearance, ILC2 accumulation and IL-13-mediated eosinophil recruitment were impaired ( Fig. 2b-d) . As expected, deletion of cytokine-expressing effector cells resulted in diminished total lung T cells as well as the proportion that were R5 + effector T H 2 cells (Fig. 2e) .
Despite the loss of ILC2s, however, CD4 + T cells in the lymph nodes made up a similar frequency of total cells, the fraction of these CD4 + cells that were CXCR5 + PD-1 + T FH cells was normal, and serum IgE responses were elevated in comparison with mice lacking the Deleter allele (Fig. 2f,g and Supplementary Fig. 3c ). Thus, IL-5-mediated deletion affects tissue immunity, but not lymph node immunity, consistent with IL-5 expression by IL-13-producing resident ILC2s and the infiltrating newly differentiating effector T H 2 cells.
Activation of adaptive type 2 immunity despite ILC2 deficiency
To further assess the contribution of ILC2s to the recruitment of T H 2 cells to tissues and IL-13-dependent worm clearance, we crossed R5/R5 and R5/R5 Deleter mice onto backgrounds deficient in the Rag1 recombinase and reconstituted them with naive CD4 + T cells from R5/+ heterozygous mice (Supplementary Fig. 3d ). Rag1-deficient mice failed to clear worms by 10 d after infection, whereas reconstituted mice cleared the infection, regardless of whether they carried the Deleter allele (Fig. 3a) . Despite substantial deletion of ILC2s (Fig. 3b) , the capacity of transferred cells to migrate to the lungs and become tissue effector T H 2 cells was unimpaired, and eosinophil recruitment was normal (Fig. 3c) . We also tested the role of major histocompatibility complex (MHC) class II expressed by ILC2s by crossing the R5/+ mice with mice carrying a loxP-flanked Although we observed a loss of MHC class II expression on ILC2s from these mice (Supplementary Fig. 3e ), we found no differences in the number of lung ILC2s, eosinophils, CD4 + T cells or R5 + effector T H 2 cells (Fig. 3d-f) . These findings are consistent with those found using an IL-13-driven Deleter allele 11 and suggest that ILC2s are not required for T FH cell function, the priming of T H 2 cells in the lymph nodes or the acquisition of T H 2 cell effector function in tissues.
Multiple tissue cytokines are required for local type 2 inflammation The findings reported above raised the possibility that local signals drive terminal differentiation of both innate lymphocytes and adaptive lymphocytes. The epithelial cytokines TSLP, IL-25 and IL-33 mediate ILC2 activation 23 and have been linked to T H 2 cell function [24] [25] [26] . In confirmation of the RNA-Seq data, we found that surface expression of the IL-33 receptor (IL-33R) and TSLP receptor (TSLPR) was similar in R5 + ILC2s and R5 + T H 2 cells (Fig. 4a) . Although undetectable in serum, the concentration of TSLP, IL-25 and IL-33 (as proteins) was elevated in the lungs after Nb infection (Fig. 4b and data not shown), which corresponded to the increased number of ILC2s and tissue effector T H 2 cells that persisted in the lungs for weeks after infection (Fig. 4c) .
The presence of multiple cytokines in the inflamed tissues, coincident with the expansion of the ILC2 and T H 2 cell compartments, suggested that there are potentially additive or synergistic signals that regulate type 2 immunity. We crossed mice that were triply deficient in TLSPR, IL-33R and IL-25 cytokine (TKO mice) 23 with mice carrying 4get and Arg1-yellow fluorescent protein (YFP) alleles, functional markers that are superior to surface markers for identification of primed Th2 cells by GFP 13 and lung ILC2s and alternatively activated macrophages (AAMs) by YFP 16 , respectively. After infection, TKO mice on both the BALB/c background and C57BL/6 background showed >90% fewer lung eosinophils and AAMs, decreased numbers of ILC2s, and delayed worm clearance compared to wildtype controls of matching backgrounds; deficits were more severe than those in single-knockout, TSLPR/IL25 or ST2/IL25 doubleknockout mice 27, 28 ( Fig. 4d-f and Supplementary Fig. 4a-d) . The number of total lung CD4 + T cells, however, was not significantly different in TKO mice, and the frequency of 4get + primed T H 2 cells in the lung tissue was only partially diminished, as compared to wild-type controls (Fig. 4g,h) . Similar results were obtained after intranasal challenge with fungal or house dust mite (HDM) extracts; in both conditions, the number of 4get + lymph node T cells and serum IgE were unaffected ( Supplementary Fig. 4e-g ), and the number of 4get + lung T cells was partially decreased, as compared to similarly challenged wild-type controls ( Supplementary Fig. 4h,i) , but the tissue type 2 immune response, as assessed by lung eosinophils and AAMs, was almost completely abrogated on both the BALB/c background ( Supplementary Fig. 4j,k) and C57BL/6 background ( Supplementary Fig. 4l,m) . The infiltration of neutrophils into tissues in response to HDM extract was unaffected, however ( Supplementary Fig. 4n ), which indicated that type 2 tissue effects were specifically abrogated in TKO mice.
Adaptive immune priming without tissue cytokines
In contrast to lung ILC2s and T H 2 cells, lymph node 4get + T cells had low expression of IL-33R and TSLPR (Fig. 5a) , and, consistent with a role for IL-33, TSLP and IL-25 in tissue responses rather than in lymph node priming, the number of early dendritic cell subsets in the draining lymph nodes was normal in TKO mice (Fig. 5b) , as were subsequent serum IgE, the number of B cells and CD4 + T cells, and the frequency of activated (CD25 + CD62L − ) and primed (CD44 + 4get + ) CD4 + T cells (Fig. 5c-e and Supplementary Fig. 5a ). Similar results were obtained after intranasal challenge with fungal or HDM extracts (Supplementary Fig. 4e-n) , and further evidence of this was borne out in a tissue site other than in the lungs. A bee venom toxin, the cytolytic enzyme phospholipase A2, induces IL-33-dependent activation of ILC2s and an allergic immune response 29 . After intraperitoneal administration of the toxin, we found that lymph node responses and the induction of IgE, along with infiltration of 4get + CD4 + T cells into tissues, were unimpaired in TKO mice (Supplementary Fig. 5b-d) , whereas peritoneal eosinophilia was substantially compromised relative to that of wild-type mice, and more so in TKO mice than in mice deficient in the IL-33R ST2 (Supplementary Fig. 5e ). Together these data demonstrated in diverse tissue sites and disparate models of allergic inflammation that although epithelial cytokines were critical for local type 2 tissue immune responses, they were not essential for the afferent processes that prime allergic immunity in draining lymph nodes.
To define the anatomic location of the terminal differentiation of effector T H 2 cells, we administered the immunomodulatory FTY720 to mice 2, 4 and 6 d after Nb infection to block the egress of lymphocytes into the circulation during priming 30 and analyzed the results on day 7. Treatment with FTY720 caused marked lymphopenia in the peripheral circulation and lungs (Supplementary Fig. 5f ) but also resulted in an increase in the frequency of lung effector T H 2 cells (Fig. 5f) , indicative of effective blockade of circulation and/or increased availability of instructive signals to the small pool of primed T cells able to reach the lungs. Although egress from lymph nodes was blocked, however, there was no accumulation of R5 + or S13 + T cells in the draining lymph nodes ( Fig. 5f and Supplementary Fig. 5g ), consistent with a lack of signals capable of mediating acquisition of full T H 2 cell production of IL-5 and IL-13 in lymph nodes.
Tissue cytokine licensing of T H 2 cells is cell intrinsic
In all of the type 2 immunological challenges noted above, primed 4get + T H 2 cells reached the lungs in TKO mice but failed to gain cytokine-secreting potential, which suggested that there was a localized deficit in terminal differentiation. To determine the functional consequence of epithelial cytokine signaling on ILC2s and primed T H 2 cells, we purified these cells from the lungs of infected mice and cultured them separately in IL-7 or IL-7 plus ionomycin and phorbol 12-myristate 13-acetate (PMA). Nb-activated ILC2s and primed 4get + T H 2 cells from the lungs of TKO mice showed markedly attenuated production of IL-5 and IL-13 under both culture conditions relative to that of cells collected from wild-type mice ( Fig. 6a and Supplementary Fig. 6a) . In confirmation of those in vitro culture results, TKO lung CD4 + T cells and ILC2s analyzed immediately ex vivo after Nb infection or HDM challenge exhibited much lower expression of the R5 and S13 reporters than that of their wild-type counterparts (Supplementary Fig. 6b-e) . Similar deficits were observed among peritoneal CD4 + T cells after challenge with phospholipase A2 (Supplementary Fig. 7a) . The inability of TKO T cells to secrete type 2 cytokines was not a result of a developmental defect, however, as in vitro culture of naive TKO CD4 + T cells resulted in normal T H 2 polarization and cytokine production (Supplementary Fig. 7b,c) . In contrast, although adoptively transferred naive CD4 + T cells lacking TSLPR and IL-33R were primed and accumulated normally in lung tissue in both wild-type and IL-25-deficient recipients (to recreate TKO conditions) after 
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Nb infection, sorted 4get + CD4 + T cells from donors lacking TSLPR and IL-33R produced significantly less IL-5 and IL-13 than similarly transferred and primed wild-type T cells (Fig. 6b) . When equal numbers of congenically marked wild-type and TKO CD4 + T cells from 4get donors were transferred into Rag1-deficient mice before Nb infection, we observed equal population expansion of wild-type and TKO total T cells and primed 4get + T H 2 cells in the lungs of recipient mice (Fig. 6c) . The primed TKO 4get + T H 2 cells, however, produced significantly less IL-5 and IL-13 than did wildtype 4get + TH2 cells after culture ex vivo either with IL-7 or with ionomycin and PMA (Fig. 6d) . We obtained similar results when we transferred wild-type or TKO cells into Rag1-deficient mice before intranasal administration of the protease allergen papain 7, 8 ( Supplementary Fig. 7d-g ).
Together the data reported above suggested that optimal effector T H 2 cell function requires local epithelial cytokine signaling in a cellintrinsic manner in response to a broad array of type 2 immunological challenges that share the ability of local tissue perturbation. To assess this with CD4 + T cells differentiating side by side in an intact immune system, we adoptively transferred wild-type congenically marked naive T cells into wild-type and TKO mice before infecting the recipients with Nb. As noted before, host ILC2s and primed T H 2 cells cultured from wild-type lungs, but not those cultured from TKO lungs, secreted IL-5 and IL-13 (Fig. 7a) . In contrast, the ability of wild-type T cells primed in TKO hosts to secrete IL-5 and IL-13 ( Fig. 7b) and mediate worm clearance (Supplementary Fig. 7h ) was equivalent to that of wild-type T cells primed in wild-type hosts. Thus, primed T cells that were intrinsically capable of sensing locally elicited tissue cytokines developed into effector T H 2 cells, even in a microenvironment in which resident dendritic cells, as well as host ILC2s and T H 2 cells unable to sense local cytokines, failed to generate type 2 effector cytokines.
DISCUSSION
Together our data suggest a model in which naive CD4 + T cells are primed in draining lymph nodes and migrate into inflamed tissues, at which point the effector differentiation of T H 2 cells is completed in response to combinatorial cytokine signals derived from the local microenvironment. These same cytokine signals also mediate ILC2 function 18 , but ILC2s themselves are not required for adaptive immune responses in the draining lymph nodes or for effector differentiation of T H 2 cells in the tissues; instead, both ILC2s and T H 2 cells are subject to a lymphocyte-intrinsic checkpoint that restricts type 2 cytokines to sites of tissue distress. Such a model might explain how type 2 immunity can be activated by diverse tissue perturbations, including proteases, venoms, chitin aggregates or mechanical injury, that do not share the microbe-associated molecular patterns that have been linked to T H 1 cell-and T H 17 cell-mediated host immunity. These findings validate the strategy of blockading tissue signals to treat allergic disease 31 , and further study will be needed to assess whether blockade of multiple pathways might prove to be a more efficacious approach than targeting of any single cytokine or receptor.
Although emerging transcriptional profiles of innate and adaptive lymphocytes subsets allow comparison of various subsets [32] [33] [34] , our approach relied on the isolation of cells from tissues on the basis of genetically encoded functional marking of cytokine-encoding genes. Although nearly all lung ILC2s constitutively produce IL-5, only a proportion of these cells become IL-13-secreting cells after allergic challenge. Among lung-infiltrating CD4 + T cells after migratory helminth infection, only a small proportion constitute the IL-13-and IL-5-secreting effector cells that mediate immunity 11 . By focusing on these tissue effector T H 2 cells, we identified substantial overlap between the chromatin landscape and the transcriptionally active components of ILC2s and tissue effector T H 2 cells. The shared transcription factor programs of these cells suggest that they have similar capacity to survey their tissue microenvironment and respond to specific tissue-localized signals, in contrast to T cells that are undergoing priming in the lymph nodes. Although published studies have indicated involvement of epithelial cytokines in type 2 immunity [23] [24] [25] [26] [27] [28] [29] 35, 36 , we found that IL-25, IL-33 and TSLP represented a shared means by which ILC2 and T H 2 cells independently acquired terminal effector function in lung tissue and thereby constituted a checkpoint for acquisition of effector cytokines. We found additional evidence for this checkpoint in peritoneum; however, separate or additional signals might mediate this acquisition across diverse tissue compartments, in which tissue-specific programs exist for other ILC subsets 37 and their helper T cell counterparts.
Published evidence suggests that tissue ILC2s are present in tissues at birth and expand their populations to reach adult levels around the time of weaning 14 . In response to tissue perturbation, ILC2s activate and expand their populations locally without exchange from blood-borne precursor cells, as has been demonstrated by parabiosis 38 . As previously shown 23 , the number of ILC2s in lung was normal in TKO mice, but, as we found in the context of adaptive immune challenges, these cells failed to express their canonical cytokines IL-5 and IL-13. Future study will be needed to elucidate the molecular pathways by which these cells, similar to the 4get + primed CD4 + T cells that accumulate in the lungs of TKO mice challenged with allergens, failed to achieve terminal effector cell differentiation. We speculate that ILC2s, which assume their position in tissues and activate cytokine expression in response to local tissue perturbations in the post-birth environment, initiate this transition in a manner similar to that later revisited by adaptive T H 2 cells arriving in peripheral tissues after priming in draining lymph nodes in response to immunological challenges. Whether some tissue effector T H 2 cells persist as long-lived tissue resident effector cells alongside developmentally positioned innate cells requires further study, but our findings for the lungs will probably extend to other T cell subsets and tissues with their own tissuespecific combinations of checkpoint signals [39] [40] [41] . Further studies of the nature and components of these checkpoints might have great therapeutic potential not only for reducing allergic pathology but also for enhancing the beneficial homeostatic pathways associated with these responses 42 .
METHODS
Methods and any associated references are available in the online version of the paper. In vivo treatments. Mice were infected subcutaneously with 500 Nb thirdstage larvae (L3), with infection and maintenance procedures as described. For adoptive transfer, naive CD4 + T cells were isolated from pooled lymph nodes and enriched to ≥98% purity by negative magnetic selection (Thermo Fisher Dynabeads or Miltenyi Biotec). Recipient C57BL/6J Rag1-deficient mice were given 10 7 donor R5/+ T cells intravenously in 250 ml sterile phosphate-buffered saline (PBS; Ca 2+ , Mg 2+ free) and were allowed to engraft for 7 d before Nb infection, then euthanized at 10 d after infection for analysis. For mixed T cell transfers (Fig. 6c,d ), 2.5 × 10 6 naive CD4 + T cells from WT 4get CD45.1/2 and TKO 4get CD45.2 BALB/c donor mice were mixed 1:1 and allowed to engraft for 15 d after transfer into Rag1-deficient BALB/c recipients, which were infected with Nb and euthanized at 8 d after infection for analysis. Recipient WT, IL-25 KO or TKO mice were irradiated sublethally (450 rads) 1 d before intravenous transfer of 2 × 10 6 donor T cells in 200 µl sterile PBS, and adoptively transferred CD4 + T cells were allowed to engraft for 18 ( Fig. 6b) or 45 (Fig. 7) d before recipient mice were infected, then euthanized at indicated time points for cell preparation and analysis.
ONLINE METHODS
Mice
Intranasal challenges with house dust mite enriched for fecal pellets (HDM; 318 fecal pellets: 28 mite bodies: 19 egg castings from Dermatophagoides farinae; Greer) or Aspergillus niger hyphal preparation were prepared and administered as previously described 44 , three times weekly for 3 weeks, followed by analysis 48 h after the final dose. Mice were injected intraperitoneally with 50 µg phospholipase A2 from bee venom (Apis mellifera; Sigma) on days 0, 7 and 13, and then euthanized on day 14 for collection of serum, lymphoid tissues and peritoneal exudate cells. For papain challenge ( Supplementary  Fig. 7 ), 2.5 × 10 6 naive CD4 + T cells from WT 4get and TKO 4get BALB/c donor mice were allowed to engraft for 15 d after transfer into Rag1-deficient BALB/c recipients, which received four doses of 30 µg papain (from Carica papaya; Sigma) intranasally on days 0, 3 7, and 9, then were euthanized on day 10 for cell preparation and analysis. FTY720 (Sigma) was dissolved in methanol for a stock solution of 5 mg/ml and this was further diluted 1:40 in normal saline before treatment. Mice received 25 µg in 200 µl (1 mg/kg) intraperitoneally on days 2, 4 and 6 post infection 30 . Vehicle-treated control mice received 200 µl of 2.5% methanol in normal saline.
